FIELD: organic chemistry, antibiotics, pharmacy. SUBSTANCE: invention relates to new antibiotics of carbapenem group and their nontoxic pharmaceutically acceptable salts exhibiting antibacterial activity. They can be used both separately and in combination with other antibiotics for treatment of human and animals with bacterial infections. Compounds of the formula (I) where moiety -S- means 5-membered heterocyclic substituted ring where: (A) Z means oxygen, sulfur atom; (B) R0 means -CH(OR4)CH3 where R4 means hydrogen atom; (C) R1 means (C1-C3)-alkyl. Substituents of a group -S- are taken from (CH2)nR2 where: (D) n is a whole number from 0 to 4; (E) R2 means: (1) methyl-group, bromine, chlorine, iodine atom, -OSO2CH3, azido-group; (II) a group of the formula -S(O)n″Ra where n'' is a whole number from 0 to 2; Ra means a group bound by carbon atom and taken from substituted or nonsubstituted (C1-C6)-alkyl, substituted or nonsubstituted phenyl, substituted or nonsubstituted phenyl-(C1-C6)-alkyl being chlorine, bromine atoms and hydroxy-group can be substituents; (III) R2 is taken from hydroxy-group, ORa, OC(O)NRaRa where Ra means independently values indicated above or where R13 means and B- is a physiologically acceptable anion; (IV) or R2 means a residue bound by nitrogen atom and means: formula (a) where Rp means oxygen atom; RL and RJ mean independently hydrogen atom, alkyl, substituted or nonsubstituted amine, heterocycle where heterocycle means 5- or 6-membered ring containing two atoms N or O; or RL and RJ with the bound nitrogen atom form nonsubstituted monocyclic ring containing two heteroatoms taken independently form O or N being substituents are hydroxyl, oxo-group; (b) acyclic quaternary ammonium group of the formula: where R7, R8, R9 mean alkyl; B- is a physiologically acceptable anion; (V) or R2 means a group bound by carbon atom and has a formula: where R2 and R3 are indicated above, and pharmaceutical acceptable salts of the compound described. Invention relates to also a method of synthesis of antibiotics of carbapenem group and some intermediate compounds. Invention proposes methods of treatment of human and animals with infectious diseases that involve administration of the above indicated compounds to human or animals and pharmaceutical preparations containing these compounds. EFFECT: improved method of synthesis and treatment. 6 cl, 14 dwg, 409 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
METHOD FOR PREPARING 6-ALKYLIDENEPENEM DERIVATIVES | 2003 |
|
RU2317297C2 |
BICYCLIC 6-ALKYLIDENEPENEMS AS β-LACTAMASE INHIBITORS | 2003 |
|
RU2339640C2 |
HEXAHYDRONAPHTHALENE ESTER DERIVATIVES, THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1994 |
|
RU2114101C1 |
BENZOXAZEPIN DERIVATIVES, THEIR PRODUCTION METHOD, MEDICINE BASED ON THEM, AND THEIR APPLICATION | 2004 |
|
RU2337100C2 |
CYTOKINES PRODUCTION-INDUCING CARBAMATES AND UREAS | 1994 |
|
RU2135515C1 |
CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
3-(3-ARYLOXYOHENYLO-1- (SUBSTITUTED METHYL)-S-TRIAZINE-2, 4,6-TRIONE DERIVATIVES, METHODS OF PREPARATION THEREOF, INTERMEDIATE COMPOUND, METHOD OR SUPPRESSING UNDESIRABLE PLANT SPECIES, AND HERBICIDAL COMPOSITION | 1996 |
|
RU2159769C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
DERIVATIVE OF THIAZOLIDINONE SHOWING COLLATERAL-DILATATING ACTIVITY OF VESSEL, PHARMACEUTICAL COMPOSITION CONTAINING ON SAID FOR TREATMENT AND PROPHYLAXIS OF STENOCARDIA AND METHOD OF SYNTHESIS OF INDICATED THIAZOLIDINONE DERIVATIVES | 1995 |
|
RU2139283C1 |
Authors
Dates
1999-05-20—Published
1994-03-15—Filed